David A. Sallman

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 18 papers. Top paper: “Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma”.

Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma

Blood Cancer Discovery(2022)10.1158/2643-3230.bcd-21-0177

N/A

3.4DataRank · unranked

75 citations

David M. Swoboda, Uri Greenbaum, Junsheng Ma, Romil Patel, Kartik Devashish +34 more

Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes

Leukemia(2022)10.1038/s41375-022-01724-9

N/A

0.926DataRank · unranked

28 citations

Jan Philipp Bewersdorf, Rena Buckstein, Mikkael A. Sekeres, David P. Steensma, Uwe Platzbecker +44 more

An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS

Blood Advances(2022)10.1182/bloodadvances.2022008747

N/A

0.525DataRank · unranked

11 citations

Omar Abdel-Wahab, Andrew H. Wei, Michael R. Savona, Mina L. Xu, Zhuoer Xie +45 more

Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients

Blood Cancer Journal(2022)10.1038/s41408-022-00622-8

N/A

0DataRank · unranked

20 citations

Terra L. Lasho, Rhett P. Ketterling, Kaaren K. Reichard, Naseema Gangat, Aref Al‐Kali +10 more

TP53‐altered acute myeloid leukemia and myelodysplastic syndrome with excess blasts should be approached as a single entity

Cancer(2022)10.1002/cncr.34535

N/A

0DataRank · unranked

17 citations

Naval Daver, Jessica K. Altman, Robert P. Hasserjian, Hagop M. Kantarjian, Uwe Platzbecker +5 more

SF3B1-mutant myelodysplastic syndrome/myeloproliferative neoplasms: a unique molecular and prognostic entity

Haematologica(2022)10.3324/haematol.2021.280463

N/A

0DataRank · unranked

8 citations

Terra L. Lasho, Christy M. Finke, Rhett P. Ketterling, Kaaren K. Reichard, Kristen McCullough +16 more

Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS)

Blood Reviews(2023)10.1016/j.blre.2023.101128

N/A

0DataRank · unranked

31 citations

Jan Philipp Bewersdorf, Zhuoer Xie, Matteo Giovanni Della Porta, Rami S. Komrokji, Mina L. Xu +43 more

Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)

Blood Reviews(2023)10.1016/j.blre.2023.101072

N/A

0DataRank · unranked

18 citations

Zhuoer Xie, Rafael Bejar, Uma Borate, Jacqueline Boultwood, Andrew M. Brunner +37 more

Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3929

N/A

0DataRank · unranked

5 citations

Maria E. Balasis, Hannah Newman, Moritz Binder, Alexis Vedder, Fumi Kinose +20 more

Data from Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma

(2023)10.1158/2643-3230.c.6550812.v1

N/A

0DataRank · unranked

0 citations

David M. Swoboda, Uri Greenbaum, Junsheng Ma, Romil Patel, Kartik Devashish +34 more

Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes—Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS])

Modern Pathology(2024)10.1016/j.modpat.2024.100615

N/A

0DataRank · unranked

12 citations

Savanah D. Gisriel, Amer M. Zeidan, John M. Bennett, Rafael Bejar, Jan Philipp Bewersdorf +48 more

Phase Ib study of PRT543, an oral protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with advanced splicing factor-mutant myeloid malignancies

Leukemia(2025)10.1038/s41375-025-02515-8

N/A

0DataRank · unranked

13 citations

Xiaoli Mi, Bin Lü, Andrew Kuykendall, David A. Sallman, Manish R. Patel +16 more

International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML

Blood Advances(2025)10.1182/bloodadvances.2025017011

N/A

0DataRank · unranked

7 citations

Richard Aplenc, Susanne H.C. Baumeister, Marco Becilli, Anand Bhagwat, Challice L. Bonifant +30 more

Evaluating the impact of stratification on the power and cross-arm balance of randomized phase 2 clinical trials

Clinical Trials(2025)10.1177/17407745241304065

N/A

0DataRank · unranked

2 citations

Michael LeBlanc, Boris Freidlin, Rory M. Shallis, Amer M. Zeidan, David A. Sallman +4 more

Evolutionary action score identifies a subset of TP53 mutated myelodysplastic syndrome with favorable prognosis

Blood Cancer Journal(2021)10.1038/s41408-021-00446-y

N/A

0DataRank · unranked

10 citations

Guillermo Montalban‐Bravo, Panagiotis Katsonis, Koji Sasaki, Caleb A. Class, Elias Jabbour +26 more

Treatment Patterns and Outcomes of Patients With Myelodysplastic Syndrome (MDS) by IPSS‐R Scores at Academic Cancer Centers

Advances in Hematology(2025)10.1155/ah/9924808

N/A

0DataRank · unranked

2 citations

Andre Hejazi, Vonetta L. Williams, Craig Comperatore, Srinivas K. Tantravahi, Najla Al Ali +14 more

Challenges in the Evaluation and Management of Toxicities Arising From Immune Checkpoint Inhibitor Therapy for Patients With Myeloid Malignancies

Clinical Lymphoma Myeloma & Leukemia(2021)10.1016/j.clml.2021.01.003

N/A

0DataRank · unranked

1 citations

Jan Philipp Bewersdorf, David M. Swoboda, Wei Wei, Lohith Gowda, Thomas Prébet +10 more

Clonal hematopoiesis is associated with increased toxicity in large B-cell lymphoma patients treated with chimeric antigen receptor T cell therapy

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.09.28.461858

N/A

0DataRank · unranked

0 citations

David M. Swoboda, Uri Greenbaum, Jungsheng Ma, Romil Patel, Kartik Devashish +32 more